Patent Litigation

Published: 10 October 2006

  • PEOPLE

    Thierry Calame
    Managing Partner, Co-Head of Intellectual Property
    M. Sterpi

  • Expertise

    Intellectual Property

  • Details

    Number of pages
    376 pages
    Publisher
    The European Lawyer Ltd.
    Language
    English
    Price
    CHF 240
    ISBN number
    0-9546523-7-1

Patent Litigation provides a unique and comprehensive overview of the complex rules surrounding international patent litigation. Clear jurisdictional comparisons help the reader to find answers to a multitude of questions covering each aspect of patent litigation in 24 countries. These comparisons are facilitated by strict adherence to a numerical template which deals with the sources of law and court system, including jurisdictional issues, issues of substantive law, parties to litigation, enforcement options, procedural issues and remedies, including preliminary relief, appeal procedures, litigation costs, forthcoming legislation and useful references. Patent Litigation is an easily accessible source of information on what can and cannot be done in patent litigation in a particular jurisdiction.  

Related publications

SEE ALL

Insights

Insights – 04.08.2026

Switzerland steps up: Federal Patent Court affirms cross-border reach in patent litigation

Switzerland steps up: Federal Patent Court affirms cross-border reach in…

<p><strong>Switzerland as a forum for cross-border patent enforcement: the Federal Patent Court confirms its reach</strong></p> <p class="MsoBodyText">In a landmark decision of 17 July 2026 (S2025_003), the Swiss Federal Patent Court has sent a clear signal: Switzerland is very much in the game when it comes to cross-border patent enforcement. The Court confirmed that claims for infringement of foreign patent designations can be heard at the defendant’s Swiss domicile and established a powerful principle of parallel infringement analysis across all EPC member states. For patent holders pursuing multi-jurisdictional strategies, Switzerland must be on the map.</p> <p class="MsoBodyText">The case arose from interim proceedings brought by Regeneron Pharmaceuticals, Inc., Bayer HealthCare LLC and Bayer Consumer Care AG against Sandoz Group AG, Sandoz AG and Sandoz Pharmaceuticals AG. The claimants sought a pan-European injunction against the distribution of Sandoz’ aflibercept biosimilar, relying on both the Swiss designation and multiple foreign designations of a European patent. The case thus presented the Court with a textbook scenario for testing Switzerland’s credentials as a cross-border patent litigation forum.</p> <p class="MsoBodyText">The Court rose to the occasion, delivering clear guidance on two issues that matter for any cross-border patent strategy:</p>

Insights – 03.11.2025

Draft bill on communication platforms and search engines in Switzerland

Draft bill on communication platforms and search engines in Switzerland

SEE ALL
Lenz & Staehelin {PAGENO}/{nbpg}
{PAGENO}/{nbpg}